Warning: The NCBI web site requires JavaScript to function. more...
The role of simple mathematical models in malaria elimination strategy design.
White LJ, Maude RJ, Pongtavornpinyo W, Saralamba S, Aguas R, Van Effelterre T, Day NP, White NJ.
Malar J. 2009 Sep 14;8:212.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.
Malar J. 2008 Nov 2;7:229.
How absolute is zero? An evaluation of historical and current definitions of malaria elimination.
Cohen JM, Moonen B, Snow RW, Smith DL.
Malar J. 2010 Jul 22;9:213. Review.
Modelling malaria elimination on the internet.
Maude RJ, Saralamba S, Lewis A, Sherwood D, White NJ, Day NP, Dondorp AM, White LJ.
Malar J. 2011 Jul 14;10:191.
Endemicity response timelines for Plasmodium falciparum elimination.
Smith DL, Hay SI.
Malar J. 2009 Apr 30;8:87.
Epidemiological models for the spread of anti-malarial resistance.
Koella JC, Antia R.
Malar J. 2003 Feb 19;2:3. Epub 2003 Feb 19.
[Development of antituberculous drugs: current status and future prospects].
Tomioka H, Namba K.
Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC.
PLoS Med. 2008 Nov 25;5(11):e226; discussion e226.
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.
Penny MA, Maire N, Studer A, Schapira A, Smith TA.
PLoS One. 2008 Sep 11;3(9):e3193.
Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model.
Filipe JA, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC.
PLoS Comput Biol. 2007 Dec;3(12):e255. Epub 2007 Nov 14.
[Current malaria situation in the Republic of Kazakhstan].
Bismil'din FB, Shapieva ZhZh, Anpilova EN.
Med Parazitol (Mosk). 2001 Jan-Mar;(1):24-33. Russian.
Conquering the intolerable burden of malaria: what's new, what's needed: a summary.
Breman JG, Alilio MS, Mills A.
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15. Review.
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations.
Lawpoolsri S, Klein EY, Singhasivanon P, Yimsamran S, Thanyavanich N, Maneeboonyang W, Hungerford LL, Maguire JH, Smith DL.
Malar J. 2009 Jul 15;8:159.
Mathematical models of malaria--a review.
Mandal S, Sarkar RR, Sinha S.
Malar J. 2011 Jul 21;10:202. Review.
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
Klein EY, Smith DL, Boni MF, Laxminarayan R.
Malar J. 2008 Apr 25;7:67.
Ecology, economics and political will: the vicissitudes of malaria strategies in Asia.
Kidson C, Indaratna K.
Parassitologia. 1998 Jun;40(1-2):39-46.
Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics.
Smith TA.
Malar J. 2008 Jan 11;7:12.
Integrated vector management for malaria control.
Beier JC, Keating J, Githure JI, Macdonald MB, Impoinvil DE, Novak RJ.
Malar J. 2008 Dec 11;7 Suppl 1:S4. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on